Salazopyrin EN
Salazopyrin EN is a medicine authorised by Swissmedic under authorisation number 30906. The authorisation holder is Pfizer AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 01 February 1965 and the authorisation is valid without a time limit. ATC code A07EC01 places the medicine in the group Antidiarrheals, intestinal anti-inflammatory and anti-infective agents.
| Authorisation number | 30906 |
|---|---|
| Name | Salazopyrin EN |
| Full name | Salazopyrin EN, magensaftresistente Filmtabletten |
| Authorisation holder | Pfizer AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | A07EC01 |
| First authorisation | 01 February 1965 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Salazopyrin EN, magensaftresistente Filmtabletten | A | 01 February 1965 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 20 | 100 | Dragée(s) | A07EC01 | 04.09.0. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Salazopyrin EN authorised in Switzerland?
Yes. Salazopyrin EN is authorised by Swissmedic under authorisation number 30906, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Salazopyrin EN have?
Salazopyrin EN is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Salazopyrin EN?
The authorisation holder is Pfizer AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.